Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Dimitris Mavroudis
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Procedures
Disorders
Chemicals & Drugs
Concepts & Ideas
Anatomy
Sign-in to see full Profile
Network (preview)
98
Georgoulias, Vassilis
44
Kakolyris, Stylianos
44
Kalbakis, Kostas
43
Agelaki, Sofia
39
Souglakos, John
34
Androulakis, Nikolaos
33
Kouroussis, Charalambos
26
Vardakis, Nikolaos
22
Vamvakas, Lambros
19
Samonis, George
17
Perraki, Maria
17
Kotsakis, Athanasios
16
Kalykaki, Antonia
15
Malamos, Nikolaos
14
Lianidou, Evi
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Dimitris Mavroudis (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Kioulafa Magdalini; Balkouranidou Ioanna; Sotiropoulou Georgia; Kaklamanis Loukas; Mavroudis Dimitris; Georgoulias Vassilis; Lianidou Evi S
Methylation of cystatin M promoter is associated with unfavorable prognosis in operable breast cancer.
International journal of cancer. Journal international du cancer 2009;125(12):2887-92.
-
2009: Saridaki Zacharenia; Pappas Periklis; Souglakos John; Nikolaidou Martha; Vardakis Nikolaos; Kotsakis Athanasios; Marselos Marios; Georgoulias Vassilis; Mavroudis Dimitris
A dose escalation and pharmacokinetic study of the biweekly administration of paclitaxel, gemcitabine and oxaliplatin in patients with advanced solid tumors.
Cancer chemotherapy and pharmacology 2009;65(1):121-8.
-
2009: Apostolaki Stella; Perraki Maria; Kallergi Galatea; Kafousi Maria; Papadopoulos Savvas; Kotsakis Athanasios; Pallis Athanasios; Xenidis Nikolaos; Kalmanti Lyda; Kalbakis Kostas; Agelaki Sofia; Kalykaki Antonia; Stournaras Christos; Stathopoulos Efstathios; Georgoulias Vassilis; Mavroudis Dimitris
Detection of occult HER2 mRNA-positive tumor cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic relevance.
Breast cancer research and treatment 2009;117(3):525-34.
-
2009: Bozionelou Vasiliki; Kalbakis Kostas; Vamvakas Lambros; Agelaki Sofia; Androulakis Nikolaos; Kalykaki Antonia; Georgoulias Vassilis; Mavroudis Dimitris
A phase I trial of gemcitabine, docetaxel and carboplatin administered every 2 weeks as first line treatment in patients with advanced breast cancer.
Cancer chemotherapy and pharmacology 2009;64(4):785-91.
-
2009: Agelaki Sophia; Spiliotaki Maria; Markomanolaki Harris; Kallergi Galatea; Mavroudis Dimitris; Georgoulias Vassilis; Stournaras Christos
Caveolin-1 regulates EGFR signaling in MCF-7 breast cancer cells and enhances gefitinib-induced tumor cell inhibition.
Cancer biology & therapy 2009;8(15):1470-7.
-
2009: Kioulafa Magdalini; Kaklamanis Loukas; Mavroudis Dimitris; Georgoulias Vassilis; Lianidou Evi S
Prognostic significance of RASSF1A promoter methylation in operable breast cancer.
Clinical biochemistry 2009;42(10-11):970-5.
-
2009: Papadaki Chara; Mavroudis Dimitris; Trypaki Maria; Koutsopoulos Anastasios; Stathopoulos Efstathios; Hatzidaki Dora; Tsakalaki Eleftheria; Georgoulias Vassilis; Souglakos John
Tumoral expression of TXR1 and TSP1 predicts overall survival of patients with lung adenocarcinoma treated with first-line docetaxel-gemcitabine regimen.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(11):3827-33.
-
2009: Kioulafa M; Kaklamanis L; Stathopoulos E; Mavroudis D; Georgoulias V; Lianidou E S
Kallikrein 10 (KLK10) methylation as a novel prognostic biomarker in early breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20(6):1020-5.
-
2009: Xenidis Nikolaos; Ignatiadis Michail; Apostolaki Stella; Perraki Maria; Kalbakis Kostas; Agelaki Sofia; Stathopoulos Efstathios N; Chlouverakis Grigorios; Lianidou Evi; Kakolyris Stylianos; Georgoulias Vassilis; Mavroudis Dimitris
Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(13):2177-84.
-
2009: Kalikaki Aristea; Kanaki Maria; Vassalou Helen; Souglakos John; Voutsina Alexandra; Georgoulias Vassilis; Mavroudis Dimitris
DNA repair gene polymorphisms predict favorable clinical outcome in advanced non-small-cell lung cancer.
Clinical lung cancer 2009;10(2):118-23.
-
2008: Ignatiadis Michail; Georgoulias Vassilis; Mavroudis Dimitris
Micrometastatic disease in breast cancer: clinical implications.
European journal of cancer (Oxford, England : 1990) 2008;44(18):2726-36.
-
2008: Kalikaki A; Koutsopoulos A; Trypaki M; Souglakos J; Stathopoulos E; Georgoulias V; Mavroudis D; Voutsina A
Comparison of EGFR and K-RAS gene status between primary tumours and corresponding metastases in NSCLC.
British journal of cancer 2008;99(6):923-9.
-
2008: Gioulbasanis Ioannis; Saridaki Zacharenia; Kalykaki Antonia; Vamvakas Lambros; Kalbakis Kostas; Ignatiadis Michail; Amarantidis Kyriakos; Kakolyris Stylianos; Georgoulias Vassilis; Mavroudis Dimitris
Gefitinib in combination with gemcitabine and vinorelbine in patients with metastatic breast cancer pre-treated with taxane and anthracycline chemotherapy: a phase I/II trial.
Anticancer research 2008;28(5B):3019-25.
-
2008: Kalbakis Kostas; Pappas Periklis; Kouroussis Charalambos; Vamvakas Lambros; Kalykaki Antonia; Vardakis Nikolaos; Nikolaidou Martha; Marselos Marios; Georgoulias Vassilis; Mavroudis Dimitris
A dose escalation and pharmacokinetic study of biweekly pegylated liposomal doxorubicin, paclitaxel and oxaliplatin in patients with advanced solid tumors.
Cancer chemotherapy and pharmacology 2008;62(3):449-56.
-
2008: Ignatiadis Michail; Kallergi Galatea; Ntoulia Maria; Perraki Maria; Apostolaki Stella; Kafousi Maria; Chlouverakis Grigorios; Stathopoulos Efstathios; Lianidou Evi; Georgoulias Vassilis; Mavroudis Dimitris
Prognostic value of the molecular detection of circulating tumor cells using a multimarker reverse transcription-PCR assay for cytokeratin 19, mammaglobin A, and HER2 in early breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(9):2593-600.
-
2008: Souglakos J; Boukovinas I; Taron M; Mendez P; Mavroudis D; Tripaki M; Hatzidaki D; Koutsopoulos A; Stathopoulos E; Georgoulias V; Rosell R
Ribonucleotide reductase subunits M1 and M2 mRNA expression levels and clinical outcome of lung adenocarcinoma patients treated with docetaxel/gemcitabine.
British journal of cancer 2008;98(10):1710-5.
-
2008: Ignatiadis Michail; Georgoulias Vassilis; Mavroudis Dimitris
Circulating tumor cells in breast cancer.
Current opinion in obstetrics & gynecology 2008;20(1):55-60.
-
2008: Kalykaki Antonia; Papakotoulas Pavlos; Tsousis Sofoklis; Boukovinas Ioannis; Kalbakis Kostas; Vamvakas Lambros; Kotsakis Athanasios; Vardakis Nikolaos; Papadopoulou Persefoni; Georgoulias Vassilis; Mavroudis Dimitris;
Gemcitabine plus oxaliplatin (GEMOX) in pretreated patients with advanced ovarian cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG).
Anticancer research 2008;28(1B):495-500.
-
2008: Georgoulias Vassilis; Androulakis Nikolaos; Kotsakis Athanasios; Hatzidaki Dora; Syrigos Kostas; Polyzos Aris; Agelidou Athina; Varthalitis Ioannis; Ziras Nikoalos; Agelidou Maria; Chandrinos Vassilis; Boukovinas Ioannis; Geroyianni Alexandra; Vamvakas Lambros; Mavroudis Dimitris
Docetaxel versus docetaxel plus gemcitabine as front-line treatment of patients with advanced non-small cell lung cancer: a randomized, multicenter phase III trial.
Lung cancer (Amsterdam, Netherlands) 2008;59(1):57-63.
-
2008: Boukovinas Ioannis; Papadaki Chara; Mendez Pedro; Taron Miquel; Mavroudis Dimitris; Koutsopoulos Anastasios; Sanchez-Ronco Maria; Sanchez Jose Javier; Trypaki Maria; Staphopoulos Eustathios; Georgoulias Vassilis; Rosell Rafael; Souglakos John
Tumor BRCA1, RRM1 and RRM2 mRNA expression levels and clinical response to first-line gemcitabine plus docetaxel in non-small-cell lung cancer patients.
PloS one 2008;3(11):e3695.
-
2008: Kallergi Galatea; Agelaki Sofia; Kalykaki Antonia; Stournaras Christos; Mavroudis Dimitris; Georgoulias Vassilis
Phosphorylated EGFR and PI3K/Akt signaling kinases are expressed in circulating tumor cells of breast cancer patients.
Breast cancer research : BCR 2008;10(5):R80.
-
2007: Ignatiadis Michail; Perraki Maria; Apostolaki Stella; Politaki Eleni; Xenidis Nikos; Kafousi Maria; Stathopoulos Efstathios; Lianidou Evi; Sotiriou Christos; Georgoulias Vassilis; Mavroudis Dimitris
Molecular detection and prognostic value of circulating cytokeratin-19 messenger RNA-positive and HER2 messenger RNA-positive cells in the peripheral blood of women with early-stage breast cancer.
Clinical breast cancer 2007;7(11):883-9.
-
2007: Ignatiadis Michail; Xenidis Nikos; Perraki Maria; Apostolaki Stella; Politaki Eleni; Kafousi Maria; Stathopoulos Efstathios N; Stathopoulou Aliki; Lianidou Evi; Chlouverakis Grigorios; Sotiriou Christos; Georgoulias Vassilis; Mavroudis Dimitris
Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(33):5194-202.
-
2007: Kouloubinis Alexandros; Kaklamanis Loukas; Ziras Nikolaos; Sofroniadou Sofia; Makaritsis Konstantinos; Adamopoulos Stamatios; Revela Ioanna; Athanasiou Athanasios; Mavroudis Dimitrios; Georgoulias Vasillios
ProANP and NT-proBNP levels to prospectively assess cardiac function in breast cancer patients treated with cardiotoxic chemotherapy.
International journal of cardiology 2007;122(3):195-201.
-
2007: Xenidis N; Markos V; Apostolaki S; Perraki M; Pallis A; Sfakiotaki G; Papadatos-Pastos D; Kalmanti L; Kafousi M; Stathopoulos E; Kakolyris S; Mavroudis D; Georgoulias V
Clinical relevance of circulating CK-19 mRNA-positive cells detected during the adjuvant tamoxifen treatment in patients with early breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(10):1623-31.
-
2007: Bolonaki Irini; Kotsakis Athanassios; Papadimitraki Elsa; Aggouraki Despoina; Konsolakis George; Vagia Aphrodite; Christophylakis Charalambos; Nikoloudi Irini; Magganas Elefterios; Galanis Athanassios; Cordopatis Paul; Kosmatopoulos Kostas; Georgoulias Vassilis; Mavroudis Dimitris
Vaccination of patients with advanced non-small-cell lung cancer with an optimized cryptic human telomerase reverse transcriptase peptide.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(19):2727-34.
-
2007: Bozionelou V; Vamvakas L; Pappas P; Agelaki S; Androulakis N; Kalykaki A; Nikolaidou M; Kentepozidis N; Giassas S; Marselos M; Georgoulias V; Mavroudis D
A dose escalation and pharmacokinetic study of biweekly pegylated liposomal doxorubicin, paclitaxel and gemcitabine in patients with advanced solid tumours.
British journal of cancer 2007;97(1):43-9.
-
2007: Apostolaki S; Perraki M; Pallis A; Bozionelou V; Agelaki S; Kanellou P; Kotsakis A; Politaki E; Kalbakis K; Kalykaki A; Vamvakas L; Georgoulias V; Mavroudis D
Circulating HER2 mRNA-positive cells in the peripheral blood of patients with stage I and II breast cancer after the administration of adjuvant chemotherapy: evaluation of their clinical relevance.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(5):851-8.
-
2007: Souglakos J; Kalykaki A; Vamvakas L; Androulakis N; Kalbakis K; Agelaki S; Vardakis N; Tzardi M; Kotsakis A P; Gioulbasanis J; Tsetis D; Sfakiotaki G; Chatzidaki D; Mavroudis D; Georgoulias V
Phase II trial of capecitabine and oxaliplatin (CAPOX) plus cetuximab in patients with metastatic colorectal cancer who progressed after oxaliplatin-based chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(2):305-10.
-
2007: Kallergi Galatea; Mavroudis Dimitris; Georgoulias Vassilis; Stournaras Christos
Phosphorylation of FAK, PI-3K, and impaired actin organization in CK-positive micrometastatic breast cancer cells.
Molecular medicine (Cambridge, Mass.) 2007;13(1-2):79-88.
-
2007: Pallis A G; Christofillakis Ch; Tselepatiotis E; Agelaki S; Vamvakas L; Souglakos J; Vardakis N; Kalykaki A; Kotsakis A; Argiraki A; Mavroudis D; Georgoulias V
Sequential administration of docetaxel followed by maintenance gefitinib, as salvage treatment in patients with advanced NSCLC: a multicenter phase II trial.
Lung cancer (Amsterdam, Netherlands) 2007;55(1):101-7.
-
2007: Saridaki Zacharenia; Bozionelou Vasiliki; Kentepozidis Nikolaos; Kotsakis Athanasios; Vardakis Nikolaos; Kalykaki Antonia; Gioulbasanis Ioannis; Karampeazis Athanasios; Vamvakas Lambros; Georgoulias Vassilis; Mavroudis Dimitris
A dose escalation study of the biweekly administration of paclitaxel, oxaliplatin and capecitabine in patients with advanced solid tumors.
Oncology 2007;72(1-2):45-50.
-
2007: Emmanouilides Christos; Sfakiotaki Georgia; Androulakis Nikolaos; Kalbakis Kostas; Christophylakis Charalambos; Kalykaki Antonia; Vamvakas Lambros; Kotsakis Athanasios; Agelaki Sofia; Diamandidou Eleni; Touroutoglou Nikolaos; Chatzidakis Adam; Georgoulias Vassilis; Mavroudis Dimitris; Souglakos John
Front-line bevacizumab in combination with oxaliplatin, leucovorin and 5-fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: a multicenter phase II study.
BMC cancer 2007;7():91.
-
2007: Souglakos J; Vardakis N; Androulakis N; Kakolyris S; Kourousis C; Mavroudis D; Pallis A; Agelaki S; Kalbakis K; Georgoulias V
Irinotecan plus weekly 5-fluorouracil and leucovorin as salvage treatment for patients with metastatic colorectal cancer: a phase II trial.
Digestive diseases (Basel, Switzerland) 2007;25(1):100-5.
-
2006: Ardavanis Alexandros; Mavroudis Dimitris; Kalbakis Kostas; Malamos Nikolaos; Syrigos Kostas; Vamvakas Lambros; Kotsakis Athanasios; Kentepozidis Nikolaos; Kouroussis Charalambos; Agelaki Sophia; Georgoulias Vassilis;
Pegylated liposomal doxorubicin in combination with vinorelbine as salvage treatment in pretreated patients with advanced breast cancer: a multicentre phase II study.
Cancer chemotherapy and pharmacology 2006;58(6):742-8.
-
2006: Pappas Periklis; Mavroudis Dimitris; Nikolaidou Martha; Georgoulias Vassilis; Marselos Marios
Coadministration of oxaliplatin does not influence the pharmacokinetics of gemcitabine.
Anti-cancer drugs 2006;17(10):1185-91.
-
2006: Boukovinas I; Androulakis N; Vamvakas L; Papakotoulas P; Ziras N; Polyzos A; Kalykaki A; Kotsakis A; Xenidis N; Gioulmbasanis I; Mavroudis D; Georgoulias V
Sequential gemcitabine and cisplatin followed by docetaxel as first-line treatment of advanced urothelial carcinoma: a multicenter phase II study of the Hellenic Oncology Research Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(11):1687-92.
-
2006: Stathopoulou Aliki; Ntoulia Maria; Perraki Maria; Apostolaki Stella; Mavroudis Dimitris; Malamos Nikos; Georgoulias Vassilis; Lianidou Evi S
A highly specific real-time RT-PCR method for the quantitative determination of CK-19 mRNA positive cells in peripheral blood of patients with operable breast cancer.
International journal of cancer. Journal international du cancer 2006;119(7):1654-9.
-
2006: Ntoulia Maria; Stathopoulou Aliki; Ignatiadis Michail; Malamos Nikos; Mavroudis Dimitris; Georgoulias Vassilis; Lianidou Evi S
Detection of Mammaglobin A-mRNA-positive circulating tumor cells in peripheral blood of patients with operable breast cancer with nested RT-PCR.
Clinical biochemistry 2006;39(9):879-87.
-
2006: Ntoulia Maria; Kaklamanis Loukas; Valavanis Christos; Kafousi Maria; Stathopoulos Efstathios; Arapantoni Petroula; Mavroudis Dimitris; Georgoulias Vassilis; Lianidou Evi S
HER-2 DNA quantification of paraffin-embedded breast carcinomas with LightCycler real-time PCR in comparison to immunohistochemistry and chromogenic in situ hybridization.
Clinical biochemistry 2006;39(9):942-6.
-
2006: Xenidis Nikos; Perraki Maria; Kafousi Maria; Apostolaki Stella; Bolonaki Irene; Stathopoulou Aliki; Kalbakis Kostas; Androulakis Nikos; Kouroussis Charalambos; Pallis Thanos; Christophylakis Charalambos; Argyraki Katerina; Lianidou Evi S; Stathopoulos Stathis; Georgoulias Vassilis; Mavroudis Dimitris
Predictive and prognostic value of peripheral blood cytokeratin-19 mRNA-positive cells detected by real-time polymerase chain reaction in node-negative breast cancer patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(23):3756-62.
-
2006: Hatzidaki Dora; Agelaki Sofia; Mavroudis Dimitris; Vlachonikolis Ioannis; Alegakis Athanasios; Georgoulias Vassilis;
A retrospective analysis of second-line chemotherapy or best supportive care in patients with advanced-stage non-small-cell lung cancer.
Clinical lung cancer 2006;8(1):49-55.
-
2006: Souglakos J; Androulakis N; Syrigos K; Polyzos A; Ziras N; Athanasiadis A; Kakolyris S; Tsousis S; Kouroussis Ch; Vamvakas L; Kalykaki A; Samonis G; Mavroudis D; Georgoulias V
FOLFOXIRI (folinic acid, 5-fluorouracil, oxaliplatin and irinotecan) vs FOLFIRI (folinic acid, 5-fluorouracil and irinotecan) as first-line treatment in metastatic colorectal cancer (MCC): a multicentre randomised phase III trial from the Hellenic Oncology Research Group (HORG).
British journal of cancer 2006;94(6):798-805.
-
2006: Karampeazis A; Vamvakas L; Agelaki S; Kentepozidis N; Papadimitraki E; Gioulbasanis I; Vardakis N; Ignatiadis M; Mavroudis D; Georgoulias V
A dose escalation study of biweekly oral vinorelbine and gemcitabine in patients with solid tumors.
Oncology 2006;71(5-6):347-53.
-
2006: Kalykaki A; Vamvakas L; Agelaki S; Kalbakis K; Vardakis N; Sfakiotaki G; Ignatiadis M; Saridaki Z; Karampeazis A; Mavroudis D; Georgoulias V
A dose escalation study of gemcitabine plus pemetrexed administered biweekly in patients with solid tumors.
Oncology 2006;71(3-4):197-203.
-
2006: Kotsakis A; Kouroussis Ch; Androulakis N; Agelaki S; Kalbakis K; Vamvakas L; Vardakis N; Kalykaki A; Polyzos A; Georgoulias V; Mavroudis D
A dose-escalation study of pegylated liposomal Doxorubicin and oxaliplatin in patients with advanced solid tumors.
Oncology 2006;71(3-4):190-6.
-
2006: Mavroudis D; Bolonakis I; Cornet S; Myllaki G; Kanellou P; Kotsakis A; Galanis A; Nikoloudi I; Spyropoulou M; Menez J; Miconnet I; Niniraki M; Cordopatis P; Kosmatopoulos K; Georgoulias V
A phase I study of the optimized cryptic peptide TERT(572y) in patients with advanced malignancies.
Oncology 2006;70(4):306-14.
-
2006: Kakolyris S; Kalbakis K; Potamianou A; Malamos N; Vamvakas L; Christophillakis C; Tselepatiotis E; Giassas S; Mavroudis D; Amarantidis K; Georgoulias V
Salvage chemotherapy with gemcitabine and oxaliplatin in heavily pretreated patients with metastatic breast cancer: a multicenter phase II study.
Oncology 2006;70(4):273-9.
-
2006: Souglakos John; Vamvakas Lambros; Apostolaki Stella; Perraki Maria; Saridaki Zacharenia; Kazakou Irine; Pallis Athanasios; Kouroussis Charalambos; Androulakis Nikos; Kalbakis Kostas; Millaki Georgia; Mavroudis Dimitris; Georgoulias Vassilis
Central nervous system relapse in patients with breast cancer is associated with advanced stages, with the presence of circulating occult tumor cells and with the HER2/neu status.
Breast cancer research : BCR 2006;8(4):R36.
-
2005: Ignatiadis Michail; Mavroudis Dimitris; Veslemes Marinos; Boukovinas John; Syrigos Kostas; Agelidou Maria; Agelidou Athina; Gerogianni Aleka; Pavlakou Georgia; Tselepatiotis Evaggelos; Nikolakopoulos John; Georgoulias Vassilis
Sequential versus alternating administration of cisplatin/etoposide and topotecan as first-line treatment in extensive-stage small-cell lung cancer: preliminary results of a Phase III Trial of the Hellenic Oncology Research Group.
Clinical lung cancer 2005;7(3):183-9.
-
2005: Georgoulias V; Agelidou A; Syrigos K; Rapti A; Agelidou M; Nikolakopoulos J; Polyzos A; Athanasiadis A; Tselepatiotis E; Androulakis N; Kalbakis K; Samonis G; Mavroudis D
Second-line treatment with irinotecan plus cisplatin vs cisplatin of patients with advanced non-small-cell lung cancer pretreated with taxanes and gemcitabine: a multicenter randomised phase II study.
British journal of cancer 2005;93(7):763-9.
-
2005: Stathopoulos E N; Sanidas E; Kafousi M; Mavroudis D; Askoxylakis J; Bozionelou V; Perraki M; Tsiftsis D; Georgoulias V
Detection of CK-19 mRNA-positive cells in the peripheral blood of breast cancer patients with histologically and immunohistochemically negative axillary lymph nodes.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(2):240-6.
-
2005: Souglakos J; Vardakis N; Androulakis N; Kakolyris S; Kouroussis Ch; Mavroudis D; Pallis A; Agelaki S; Kalbakis K; Georgoulias V
Irinotecan plus weekly 5-fluorouracil and leucovorin as salvage treatment for patients with metastatic colorectal cancer: A phase II trial.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology 2005;10(1):47-52.
-
2005: Souglakos J; Pallis A; Kakolyris S; Mavroudis D; Androulakis N; Kouroussis C; Agelaki S; Xenidis N; Milaki G; Georgoulias V
Combination of irinotecan (CPT-11) plus 5-fluorouracil and leucovorin (FOLFIRI regimen) as first line treatment for elderly patients with metastatic colorectal cancer: a phase II trial.
Oncology 2005;69(5):384-90.
-
2005: Souglakos John; Kakolyris Stylianos; Vardakis Nikolaos; Androulakis Nikolaos; Mavroudis Dimitrios; Vamvakas Lambos; Kouroussis Charalambos; Agelaki Sophia; Saridaki Zacharenia; Georgoulias Vassilis
A dose escalating study of oxaliplatin and high dose weekly leucovorin and 5-Fluorouracil in patients with advanced solid tumors.
Cancer investigation 2005;23(6):505-10.
-
2004: Bozionellou Vassiliki; Mavroudis Dimitris; Perraki Maria; Papadopoulos Savvas; Apostolaki Stella; Stathopoulos Efstathios; Stathopoulou Aliki; Lianidou Evi; Georgoulias Vassilis
Trastuzumab administration can effectively target chemotherapy-resistant cytokeratin-19 messenger RNA-positive tumor cells in the peripheral blood and bone marrow of patients with breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(24):8185-94.
-
2004: Kouroussis Charalambos; Mavroudis Dimitris; Kakolyris Stylianos; Voloudaki Argyro; Kalbakis Konstantinos; Souglakos John; Agelaki Sophia; Malas Konstantinos; Bozionelou Vassiliki; Georgoulias Vassilis
High incidence of pulmonary toxicity of weekly docetaxel and gemcitabine in patients with non-small cell lung cancer: results of a dose-finding study.
Lung cancer (Amsterdam, Netherlands) 2004;44(3):363-8.
-
2004: Giatromanolaki Alexandra; Koukourakis Michael I; Kakolyris Stelios; Mavroudis Dimitris; Kouroussis Charalambos; Mavroudi Chrysa; Perraki Maria; Sivridis Efthimios; Georgoulias Vassilis
Assessment of highly angiogenic and disseminated in the peripheral blood disease in breast cancer patients predicts for resistance to adjuvant chemotherapy and early relapse.
International journal of cancer. Journal international du cancer 2004;108(4):620-7.
-
2004: Mavroudis D; Malamos N; Polyzos A; Kouroussis Ch; Christophilakis Ch; Varthalitis I; Androulakis N; Kalbakis K; Milaki G; Georgoulias V;
Front-line chemotherapy with docetaxel and gemcitabine administered every two weeks in patients with metastatic breast cancer: a multicenter phase II study.
Oncology 2004;67(3-4):250-6.
-
2004: Kakolyris S; Souglakos J; Kouroussis C; Androulakis N; Samonis G; Vardakis N; Amarantidis K; Agelaki S; Mavroudis D; Xenidis N; Georgoulias V
Dose escalation study on oxaliplatin and capecitabine (Xeloda) in patients with advanced solid tumors.
Oncology 2004;66(4):253-9.
-
2003: Samonis George; Maraki Sofia; Kouroussis Charalambos; Mavroudis Dimitrios; Georgoulias Vassilios
Salmonella enterica pneumonia in a patient with lung cancer.
Journal of clinical microbiology 2003;41(12):5820-2.
-
2003: Dimitriou Helen; Vorgia Pelagia; Stiakaki Eftichia; Mavroudis Dimitris; Markaki Erasmia Athina; Koumantakis Eugene; Kalmanti Maria
In vitro proliferative and differentiating characteristics of CD133(+) and CD34(+) cord blood cells in the presence of thrombopoietin (TPO) or erythropoietin (EPO). Potential implications for hematopoietic cell transplantation.
Leukemia research 2003;27(12):1143-51.
-
2003: Stathopoulou Aliki; Gizi Anna; Perraki Maria; Apostolaki Stella; Malamos Nikos; Mavroudis Dimitris; Georgoulias Vassilis; Lianidou Evi S
Real-time quantification of CK-19 mRNA-positive cells in peripheral blood of breast cancer patients using the lightcycler system.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(14):5145-51.
-
2003: Souglakos John; Androulakis Nikolaos; Mavroudis Dimitrios; Kourousis Charalabos; Kakolyris Stylianos; Vardakis Nikolaos; Kalbakis Konstantinos; Pallis Athanasios; Ardavanis Alexandros; Varveris Charalabos; Georgoulias Vassilios
Multicenter dose-finding study of concurrent capecitabine and radiotherapy as adjuvant treatment for operable rectal cancer.
International journal of radiation oncology, biology, physics 2003;56(5):1284-7.
-
2003: Xenidis N; Vlachonikolis I; Mavroudis D; Perraki M; Stathopoulou A; Malamos N; Kouroussis C; Kakolyris S; Apostolaki S; Vardakis N; Lianidou E; Georgoulias V
Peripheral blood circulating cytokeratin-19 mRNA-positive cells after the completion of adjuvant chemotherapy in patients with operable breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(6):849-55.
-
2003: Pallis A G; Mavroudis D; Androulakis N; Souglakos J; Kouroussis C; Bozionelou V; Vlachonikolis I G; Georgoulias V
ZD1839, a novel, oral epidermal growth factor receptor-tyrosine kinase inhibitor, as salvage treatment in patients with advanced non-small cell lung cancer. Experience from a single center participating in a compassionate use program.
Lung cancer (Amsterdam, Netherlands) 2003;40(3):301-7.
-
2003: Stathopoulou A; Mavroudis D; Perraki M; Apostolaki S; Vlachonikolis I; Lianidou E; Georgoulias V
Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.
Anticancer research 2003;23(2C):1883-90.
-
2003: Mavroudis D; Pappas P; Kouroussis C; Kakolyris S; Agelaki S; Kalbakis K; Androulakis N; Souglakos J; Vardakis N; Nikolaidou M; Samonis G; Marselos M; Georgoulias V
A dose-escalation and pharmacokinetic study of gemcitabine and oxaliplatin in patients with advanced solid tumors.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(2):304-12.
-
2003: Kouroussis Charalambos; Agelaki Sophia; Mavroudis Dimitris; Kakolyris Stylianos; Androulakis Nick; Kalbakis Kostas; Souglakos John; Mallas Kostas; Bozionelou Vassiliki; Pallis Athanasios; Adamtziki Helen; Georgoulias Vassilis
A dose escalation study of docetaxel and oxaliplatin combination in patients with metastatic breast and non-small cell lung cancer.
Anticancer research 2003;23(1B):785-91.
-
2003: Mavroudis D; Pavlakou G; Blazoyiannakis G; Veslemes M; Apostolopoulou F; Kouroussis Ch; Kakolyris S; Agelaki S; Androulakis N; Vardakis N; Magkanas E; Samonis G; Georgoulias V
Sequential administration of cisplatin-etoposide followed by topotecan in patients with extensive stage small cell lung cancer. A multicenter phase II study.
Lung cancer (Amsterdam, Netherlands) 2003;39(1):71-6.
-
2003: Mavroudis D; Alexopoulos A; Malamos N; Ardavanis A; Kandylis C; Stavrinidis E; Kouroussis Ch; Agelaki S; Androulakis N; Bozionelou V; Georgoulias V
Salvage treatment of metastatic breast cancer with docetaxel and carboplatin. A multicenter phase II trial.
Oncology 2003;64(3):207-12.
-
2002: Kouroussis Charalambos; Souglakos John; Mavroudis Dimitris; Papadouris Savvakis; Kakolyris Stylianos; Agelaki Sophia; Kalbakis Kostas; Panopoulos Christos; Vardakis Nikos; Sarra Evanthia; Georgoulias Vassilis
Oxaliplatin with high-dose leucovorin and infusional 5-fluorouracil in irinotecan-pretreated patients with advanced colorectal cancer (ACC).
American journal of clinical oncology 2002;25(6):627-31.
-
2002: Androulakis N; Kouroussis C; Mavroudis D; Kakolyris S; Souglakos J; Agelaki S; Kalbakis K; Malas K; Pallis A; Samonis G; Georgoulias V
Phase I study of weekly paclitaxel and liposomal doxorubicin in patients with advanced solid tumours.
European journal of cancer (Oxford, England : 1990) 2002;38(15):1992-7.
-
2002: Mavroudis D; Veslemes M; Kouroussis Ch; Tzanakis N; Ferdoutsis E; Toumbis M; Ziotopoulos P; Agelidou M; Tselepatiotis E; Kalbakis K; Souglakos J; Magkanas E; Samonis G; Georgoulias V;
Cisplatin-etoposide alternating with topotecan in patients with extensive stage small cell lung cancer (SCLC). A multicenter phase II study.
Lung cancer (Amsterdam, Netherlands) 2002;38(1):59-63.
-
2002: Souglakos John; Kotsakis Athanaslos; Kouroussis Charalambos; Kakolyris Stylianos; Mavroudis Dimitrios; Kalbakis Konstadinos; Agelaki Sofia; Vlachonikolis John; Georgoulias Vassilis; Samonis George
Nonneutropenic febrile episodes associated with docetaxel-based chemotherapy in patients with solid tumors.
Cancer 2002;95(6):1326-33.
-
2002: Stathopoulou A; Vlachonikolis I; Mavroudis D; Perraki M; Kouroussis Ch; Apostolaki S; Malamos N; Kakolyris S; Kotsakis A; Xenidis N; Reppa D; Georgoulias V
Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic significance.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(16):3404-12.
-
2002: Souglakos J; Mavroudis D; Kakolyris S; Kourousis Ch; Vardakis N; Androulakis N; Agelaki S; Kalbakis K; Tsetis D; Athanasiadis N; Samonis G; Georgoulias V
Triplet combination with irinotecan plus oxaliplatin plus continuous-infusion fluorouracil and leucovorin as first-line treatment in metastatic colorectal cancer: a multicenter phase II trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(11):2651-7.
-
2002: Vamvakas L; Kakolyris S; Kouroussis C; Kandilis K; Mavroudis D; Ziras N; Androulakis N; Kalbakis K; Sarra E; Souglakos J; Georgoulias V;
Irinotecan (CPT-11) in combination with infusional 5-fluorouracil and leucovorin (de Gramont regimen) as first-line treatment in patients with advanced colorectal cancer: a multicenter phase II study.
American journal of clinical oncology 2002;25(1):65-70.
-
2002: Kakolyris S; Kouroussis C; Koukourakis M; Mavroudis D; Malas K; Vardakis N; Bozionelou V; Kalbakis K; Georgoulias V
A dose-escalation study of oxaliplatin and vinorelbine in patients with advanced solid tumors.
Oncology 2002;63(3):213-8.
-
2002: Mavroudis D; Kouroussis Ch; Kakolyris S; Agelaki S; Kalbakis K; Androulakis N; Souglakos J; Samonis G; Georgoulias V
Phase I study of paclitaxel (taxol) and pegylated liposomal doxorubicin (caelyx) administered every 2 weeks in patients with advanced solid tumors.
Oncology 2002;62(3):216-22.
-
2002: Kosmas C; Agelaki S; Giannakakis Th; Mavroudis D; Kouroussis Ch; Kalbakis K; Papadouris S; Souglakos J; Malamos N; Georgoulias V
Phase I study of vinorelbine and carboplatin combination in patients with taxane and anthracycline pretreated advanced breast cancer.
Oncology 2002;62(2):103-9.
-
2001: Georgoulias V; Samonis G; Papadakis E; Alexopoulos A; Tsiafaki X; Rapti A; Veslemes M; Grigoratou T; Palamidas P; Kouroussis C; Mavroudis D; Kakolyris S; Giannakakis T; Vlachonikolis J;
Comparison of docetaxel/cisplatin to docetaxel/gemcitabine as first-line treatment of advanced non-small cell lung cancer: early results of a randomized trial.
Lung cancer (Amsterdam, Netherlands) 2001;34 Suppl 4():S47-51.
-
2001: Agelaki S; Kakolyris S; Palamidas P; Kouroussis C; Mavroudis D; Kalbakis K; Georgoulias V; Raptis A
A dose escalation study of topotecan in combination with epirubicin in pretreated patients with small-cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2001;34(1):133-9.
-
2001: Kalbakis K; Kouroussis C; Kakolyris S; Mavroudis D; Souglakos J; Agelaki S; Vamvakas L; Christodoulakis M; Stylianou K; Georgoulias V
Salvage chemotherapy with high-dose leucovorin (LV) and 48-hour continuous infusion (CI) of 5-fluorouracil (5-FU) in combination with conventional doses of cyclophosphamide (CPM) in patients with metastatic breast cancer (MBC) pretreated with anthracycline and taxanes.
British journal of cancer 2001;85(6):798-802.
-
2001: Kouroussis C; Kakolyris S; Mavroudis D; Androulakis N; Kalbakis K; Agelaki S; Sarra E; Souglakos J; Christodoulakis M; Samonis G; Georgoulias V
A dose-finding study of the weekly administration of paclitaxel in patients with advanced solid tumors.
American journal of clinical oncology 2001;24(4):404-7.
-
2001: Alexopoulos A; Kouroussis C; Malamos N; Kakolyris S; Kalbakis K; Kosmas C; Mavroudis D; Agelaki S; Vlachonicolis J; Sarra E; Rigatos G; Georgoulias V
Docetaxel in combination with mitoxantrone and granulocyte colony-stimulating factor as front-line chemotherapy in metastatic breast cancer: a multicenter phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(6):793-8.
-
2001: Mavroudis D; Papadakis E; Veslemes M; Tsiafaki X; Stavrakakis J; Kouroussis C; Kakolyris S; Bania E; Jordanoglou J; Agelidou M; Vlachonicolis J; Georgoulias V;
A multicenter randomized clinical trial comparing paclitaxel-cisplatin-etoposide versus cisplatin-etoposide as first-line treatment in patients with small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(4):463-70.
-
2001: Stathopoulos G P; Mavroudis D; Tsavaris N; Kouroussis C; Aravantinos G; Agelaki S; Kakolyris S; Rigatos S K; Karabekios S; Georgoulias V
Treatment of pancreatic cancer with a combination of docetaxel, gemcitabine and granulocyte colony-stimulating factor: a phase II study of the Greek Cooperative Group for Pancreatic Cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(1):101-3.
-
2001: Kouroussis C; Souglakos J; Kakolyris S; Mavroudis D; Malamos N; Kalbakis K; Androulakis N; Agelaki A; Vardakis N; Samonis G; Georgoulias V
Oxaliplatin in combination with infusional 5-fluorouracil and leucovorin every 2 weeks as first-line treatment in patients with advanced colorectal cancer: a phase II study.
Oncology 2001;61(1):36-41.
-
2001: Kakolyris S; Souglakos J; Kouroussis C; Androulakis N; Mavroudis D; Kalbakis K; Kotsakis A; Vardakis N; Koukourakis M; Romanos J; Georgoulias V
A dose-finding study of irinotecan (CPT-11) plus a four-day continuous 5-fluorouracil infusion in advanced colorectal cancer.
Oncology 2001;60(3):207-13.
-
2000: Kakolyris S; Souglakos J; Agelaki S; Kourousis C H; Mavroudis D; Sarra E; Malliotakis P; Georgoulias V
A dose-escalation study of irinotecan (CPT-11) in combination with cisplatin in patients with advanced non-small cell lung cancer previously treated with a docetaxel-based front line chemotherapy.
Lung cancer (Amsterdam, Netherlands) 2000;30(3):193-8.
-
2000: Mavroudis D; Alexopoulos A; Ziras N; Malamos N; Kouroussis C; Kakolyris S; Agelaki S; Kalbakis K; Tsavaris N; Potamianou A; Rigatos G; Georgoulias V
Front-line treatment of advanced breast cancer with docetaxel and epirubicin: a multicenter phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(10):1249-54.
-
2000: Mavroudis D; Kourousis C; Androulakis N; Kalbakis K; Agelaki S; Kakolyris S; Souglakos J; Sarra E; Vardakis N; Hatzidaki D; Sarmonis G; Georgoulias V
Frontline treatment of advanced gastric cancer with docetaxel and granulocyte colony-stimulating factor (G-CSF): a phase II trial.
American journal of clinical oncology 2000;23(4):341-4.
-
2000: Kakolyris S; Kouroussis C; Kalbakis K; Mavroudis D; Souglakos J; Nvardakis; Kremos S; Georgoulias V
Salvage treatment of advanced non-small-cell lung cancer previously treated with docetaxel-based front-line chemotherapy with irinotecan (CPT-11) in combination with cisplatin.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(6):757-60.
-
2000: Giannakakis T; Ziras N; Kakolyris S; Mavroudis D; Androulakis N; Agelaki S; Parashos M; Sarra E; Dimou T; Hatzidaki D; Vlachonikolis J; Georgoulias V
Docetaxel in combination with carboplatin for the treatment of advanced non-small cell lung carcinoma: a multicentre phase I study.
European journal of cancer (Oxford, England : 1990) 2000;36(6):742-7.
-
2000: Mavroudis D; Kourousis C; Kakolyris S; Agelaki S; Kalbakis K; Androulakis N; Souglakos J; Vardakis N; Samonis G; Georgoulias V
Phase I study of the gemcitabine/oxaliplatin combination in patients with advanced solid tumors: a preliminary report.
Seminars in oncology 2000;27(1 Suppl 2):25-30.
-
2000: Kouroussis C; Agelaki S; Mavroudis D; Souglakos J; Kakolyris S; Kalbakis K; Vardakis N; Reppa D; Hatzidaki D; Samonis G; Georgoulias V
A dose escalation study of weekly docetaxel in patients with advanced solid tumors.
Cancer chemotherapy and pharmacology 2000;46(6):488-92.
-
1999: Kouroussis C; Xydakis E; Potamianou A; Giannakakis T; Kakolyris S; Agelaki S; Sara E; Malamos N; Alexopoulos A; Mavroudis D; Samonis G; Papadouris S; Georgoulias V; Panagos G
Front-line treatment of metastatic breast cancer with docetaxel and epirubicin: a multicenter dose-escalation study. The Greek Breast Cancer Cooperative Group (GBCCG).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(5):547-52.
-
1999: Kouroussis C; Androulakis N; Kakolyris S; Souglakos J; Kotsakis T; Mavroudis D; Katsogridakis K; Vardakis N; Hatzidaki D; Samonis G; Vlachonikolis J; Georgoulias V
Dose-escalation study of docetaxel in combination with mitoxantrone as first-line treatment in patients with metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(3):862-9.
-
1999: Mavroudis D; Malamos N; Alexopoulos A; Kourousis C; Agelaki S; Sarra E; Potamianou A; Kosmas C; Rigatos G; Giannakakis T; Kalbakis K; Apostolaki F; Vlachonicolis J; Kakolyris S; Samonis G; Georgoulias V
Salvage chemotherapy in anthracycline-pretreated metastatic breast cancer patients with docetaxel and gemcitabine: a multicenter phase II trial. Greek Breast Cancer Cooperative Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(2):211-5.
Sign-in to see more
